Travere Therapeutics, Inc. TVTX Free cash flow
Discontinued — last reported Q3 '24
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Travere Therapeutics, Inc.’s reported figures.
The official record: Travere Therapeutics, Inc.’s 10-Q, filed October 30, 2025, on SEC EDGAR. View the filing →
Ask your AI about Travere Therapeutics, Inc.'s free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Travere Therapeutics, Inc.'s free cash flow?
- Travere Therapeutics, Inc. (TVTX) reported free cash flow of -$42.51M in Q3 2024.
- How has Travere Therapeutics, Inc.'s free cash flow changed year-over-year?
- Travere Therapeutics, Inc.'s free cash flow increased by 28.1% year-over-year, from -$59.14M to -$42.51M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.